Kumar Group
Welcome to the Kumar Group! Our group is dedicated to advancing the frontiers of organic chemistry, medicinal chemistry, and drug discovery.
Welcome to the Kumar Group! Our group is dedicated to advancing the frontiers of organic chemistry, medicinal chemistry, and drug discovery.
Our research group focuses on the design and development of novel therapeutic agents through the integration of medicinal chemistry, chemical biology, and advanced computational drug discovery approaches. We work on various projects targeting different disease areas, with a particular emphasis on cancer and infectious diseases.
We design and synthesise new compounds, investigate how they act on biological targets, and study how changes to their chemical structures affect their activity. Our research spans antimicrobial agents and materials, potential cancer treatments, and computational methods that help identify and refine promising drug candidates. Beyond therapeutic discovery, we develop synthetic methods for making useful chemical structures and investigate chemical approaches to removing persistent PFAS contaminants from the environment.
New antimicrobial agents: Designing peptide mimics to combat drug-resistant bacteria, and studying how their chemical structures affect their activity, selectivity and mechanisms of action.
Antimicrobial materials and biofilm control: Developing antibacterial hydrogels, coatings and modified surfaces for medical devices and industrial settings, including materials that release nitric oxide or respond to light.
Bacterial signalling and transcription: Creating small molecules that disrupt quorum sensing or the protein interactions needed to initiate bacterial transcription, with the aim of identifying leads for new antibiotics.
Cancer drug discovery: Synthesising and testing compounds that target USP5 and MYCN in neuroblastoma and glioblastoma, FLT3 in acute myeloid leukaemia, and altered glucose metabolism in cancer cells. This work also explores anticancer isoflavone analogues.
Computational drug discovery: Using machine learning, virtual screening, molecular docking and simulations to identify promising antimicrobial peptides and guide the design of more effective compounds.
PFAS remediation: Developing systems that combine materials that capture PFAS with catalysts designed to break down these persistent chemicals.
Synthetic methods: Creating practical routes to indoles and benzodiazepinones, giving researchers access to diverse compounds for medicinal chemistry.